Urgent

Progressive multifocal leukoencephalopathy (JC virus)

PML · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

PML is a demyelinating CNS infection caused by JC polyomavirus reactivation in profound immunosuppression (advanced HIV, natalizumab, other biologics, haematological malignancy). There is no specific antiviral; restoring immune function is the only effective strategy.

Red flags

  • Rapidly progressive hemiparesis, aphasia or visual field loss
  • New seizures
  • Deterioration after immune recovery (IRIS)
  • Coma or brainstem involvement
  • Recent natalizumab with rising JC antibody index

Assessment

Differential diagnosis

  • HIV encephalopathy
  • CNS lymphoma
  • Cerebral toxoplasmosis
  • CMV or HSV encephalitis
  • Immune reconstitution inflammatory syndrome
  • Demyelination/MS relapse

Investigations

  • MRI brain (asymmetric subcortical white-matter lesions, no enhancement/mass effect typically)
  • CSF JC virus PCR
  • CD4 count and HIV viral load
  • Review of immunosuppressive/biologic exposure (e.g. natalizumab, JC antibody index)
  • Brain biopsy if PCR negative but high suspicion
  • Baseline neurological function assessment

Management

  • Suspect in immunosuppressed patient with progressive focal neurological deficit
  • Obtain MRI brain and CSF JC virus PCR
  • Review all immunosuppressant exposure, especially natalizumab/biologics
  • Stop or reverse the causative immunosuppressant where possible (e.g. plasma exchange for natalizumab)
  • In HIV, start or optimise ART urgently to achieve immune recovery
  • Anticipate and manage immune reconstitution inflammatory syndrome (may use corticosteroids)
  • Provide neurorehabilitation and supportive care
  • Monitor clinically and with repeat imaging
  • Consider experimental immune-based therapies in specialist centres
  • Manage seizures and complications as they arise
  • Counsel patient and family on guarded prognosis
  • Multidisciplinary neurology/ID involvement

Drugs & doses

Optimised combination antiretroviral therapy (HIV-associated PML) - regimen as per resistance
Corticosteroids (e.g. methylprednisolone) for PML-IRIS inflammatory deterioration
Mirtazapine 15-30 mg PO at night (adjunct, 5-HT2A blockade - limited evidence)
No proven specific antiviral (cidofovir/cytarabine not recommended)

Disposition

Admit for workup; neurology and ID co-management; specialist centre referral.

Complications & pitfalls

  • Severe permanent neurological disability
  • PML immune reconstitution inflammatory syndrome
  • Seizures
  • Death
  • Aspiration and immobility complications

Exam pearls

  • Restoring immunity is the mainstay; there is no effective antiviral
  • Natalizumab-associated PML warrants plasma exchange to remove drug
  • IRIS may paradoxically worsen clinical state as the lesion becomes inflamed
  • Enhancement on MRI is atypical and suggests IRIS or alternative diagnosis
  • JC antibody index stratifies PML risk in patients on natalizumab

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.